Search results
Eosinophilic Asthma
Health via Yahoo News· 11 hours agoThere are four FDA-approved biologic therapies for treating eos asthma, including: Fasenra (benralizumab): Prevents inflammatory cytokine interleukin-5...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with...
Benzinga· 7 days agoFood and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) as an add-on maintenance ...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 6 days agoCRSwNP is a chronic inflammatory disease that can lead to breathing difficulties, nasal congestion,...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 6 days agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
FDA considers Dupixent for adolescent sinusitis treatment By Investing.com
Investing.com· 7 days agoThe U.S. Food and Drug Administration (FDA) has granted Priority Review for the supplemental...
Sanofi Invests €1 Billion in French Drug Manufacturing
Bloomberg· 7 days agoSanofi will invest more than €1 billion ($1.08 billion) at three facilities in France as it ramps up...
Sanofi boosts French biomanufacturing with €1 billion investment
Investing.com· 7 days agoSanofi (EPA: SASY ) (NASDAQ: SNY ), a global biopharmaceutical company, announced today a...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 5 days agoThese products have the potential to address the needs of millions of patients both in...
J&J hooks Proteologix for $850M cash, reeling in a roster of early bispecifics
FierceBiotech· 3 days agoJohnson & Johnson is shelling out $850 million to buy Proteologix, getting hold of a young roster of...
